BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21908064)

  • 1. Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy.
    Nguyen NP; Krafft SP; Vinh-Hung V; Vos P; Almeida F; Jang S; Ceizyk M; Desai A; Davis R; Hamilton R; Modarresifar H; Abraham D; Smith-Raymond L
    Radiother Oncol; 2011 Dec; 101(3):438-42. PubMed ID: 21908064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.
    Chen YJ; Liu A; Han C; Tsai PT; Schultheiss TE; Pezner RD; Vora N; Lim D; Shibata S; Kernstine KH; Wong JY
    Med Dosim; 2007; 32(3):166-71. PubMed ID: 17707195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helical tomotherapy-based STAT RT: Dosimetric evaluation for clinical implementation of a rapid radiation palliation program.
    McIntosh A; Dunlap N; Sheng K; Geezey C; Turner B; Blackhall L; Weiss G; Lappinen E; Larner JM; Read PW
    Med Dosim; 2010; 35(4):280-6. PubMed ID: 19944589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma.
    Martin S; Chen JZ; Rashid Dar A; Yartsev S
    Radiother Oncol; 2011 Dec; 101(3):431-7. PubMed ID: 21962823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer.
    Han C; Schiffner DC; Schultheiss TE; Chen YJ; Liu A; Wong JY
    Radiother Oncol; 2012 Feb; 102(2):309-14. PubMed ID: 21872956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy for soft tissue sarcomas of extremities. Preliminary comparative dosimetric study of 3D conformal radiotherapy versus helical tomotherapy].
    Donnay L; Dejean C; Amsellem E; Bourezgui H; de Figueiredo BH; Duparc A; Caron J; Tournat H; Lagarde P; Stoeckle E; Kantor G
    Cancer Radiother; 2008 Dec; 12(8):809-16. PubMed ID: 19046919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisegmented tangential breast fields: a rational way to treat breast cancer.
    Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
    Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
    Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
    Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
    Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique.
    Goddu SM; Chaudhari S; Mamalui-Hunter M; Pechenaya OL; Pratt D; Mutic S; Zoberi I; Jeswani S; Powell SN; Low DA
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1243-51. PubMed ID: 19251096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
    Soisson ET; Tomé WA; Richards GM; Mehta MP
    Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.